文献速递小儿眼科与斜弱视

新型定量对比敏感度功能增强对弱视治疗结果和复发的预测

Novel Quantitative Contrast Sensitivity Function Enhances the Prediction of Treatment Outcome and Recurrence in Amblyopia.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

本研究利用643例弱视患者共2559条连续记录,比较传统视力表视力与新型定量对比敏感度功能(CSF)作为预测变量,结合六种机器学习方法构建模型预测治疗反应和复发。结果显示联合视力与CSF变量预测3个月和6个月治疗反应的AUC分别为0.863和0.815,CSF变量预测复发的AUC为0.909,而单独视力预测复发AUC仅0.539,眼间CSF特征差异是复发风险的重要贡献因素。

要点

  • 联合视力与CSF变量预测3个月和6个月治疗反应的AUC分别为0.863和0.815。
  • CSF变量预测弱视复发的AUC为0.909,单独视力预测复发AUC为0.539。
  • 眼间CSF特征差异是复发风险的重要贡献因素。

核心结论

  • CSF数据可增强治疗反应预测并准确预测弱视复发,有潜力通过实现患者个体化决策来指导弱视管理。

研究设计与样本

  • 从643例弱视患者的2559条连续记录中提取58个潜在预测变量,以传统视力表视力和新型CSF评估为主要预测变量。
  • 应用六种机器学习方法构建预测治疗反应和复发的模型,并使用SHapley Additive exPlanations解释预测。

主要发现

  • 联合视力和CSF变量预测治疗反应的准确率最高,预测3个月和6个月结果的AUC分别为0.863和0.815。
  • 单独视力变量预测治疗反应的AUC在3个月和6个月分别为0.723和0.675。
  • CSF变量预测复发的AUC为0.909,而单独视力评估为0.539,加入视力变量未改善预测性能。
  • 眼间CSF特征差异是复发风险的重要贡献因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although effective amblyopia treatments are available, treatment outcome is unpredictable, and the condition recurs in up to 25% of the patients. We aimed to evaluate whether a large-scale quantitative contrast sensitivity function (CSF) data source, coupled with machine learning (ML) algorithms, can predict amblyopia treatment response and recurrence in individuals. METHODS: Visual function measures from traditional chart vision acuity (VA) and novel CSF assessments were used as the main predictive variables in the models. Information from 58 potential predictors was extracted to predict treatment response and recurrence. Six ML methods were applied to construct models. The SHapley Additive exPlanations was used to explain the predictions. RESULTS: A total of 2559 consecutive records of 643 patients with amblyopia were eligible for modeling. Combining variables from VA and CSF assessments gave the highest accuracy for treatment response prediction, with the area under the receiver operating characteristic curve (AUC) of 0.863 and 0.815 for outcome predictions after 3 and 6 months, respectively. Variables from the VA assessment alone predicted the treatment response, with AUC values of 0.723 and 0.675 after 3 and 6 months, respectively. Variables from the CSF assessment gave rise to an AUC of 0.909 for recurrence prediction compared to 0.539 for VA assessment alone, and adding VA variables did not improve predictive performance. The interocular differences in CSF features are significant contributors to recurrence risk. CONCLUSIONS: Our models showed CSF data could enhance treatment response prediction and accurately predict amblyopia recurrence, which has the potential to guide amblyopia management by enabling patient-tailored decision making.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Liu J, Huang C, Cotter SA, et al. Novel Quantitative Contrast Sensitivity Function Enhances the Prediction of Treatment Outcome and Recurrence in Amblyopia. Invest Ophthalmol Vis Sci. 2024. PMID: 38771572. doi:10.1167/iovs.65.5.31

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。